반응식
Cl[C:2]([N:4]1[C:10]2[CH:11]=[CH:12][CH:13]=[CH:14][C:9]=2[C:8](=[O:15])[NH:7][C:6]2[CH:16]=[CH:17][CH:18]=[N:19][C:5]1=2)=[O:3].[CH3:20][NH:21][CH2:22][C:23]#[CH:24]>>[CH3:20][N:21]([CH2:22][C:23]#[CH:24])[C:2]([N:4]1[C:10]2[CH:11]=[CH:12][CH:13]=[CH:14][C:9]=2[C:8](=[O:15])[NH:7][C:6]2[CH:16]=[CH:17][CH:18]=[N:19][C:5]1=2)=[O:3]참가 물질
3
실험 절차
Analogously to Example C, using 27.3 g (0.1 mol) of 11-chlorocarbonyl-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one and 7.0 g (0.1 mol) of N-methyl-propargylamine, 27 g (88% of theory) of the desired compound are obtained.
출처 및 근거
- ORD 기록
- ord-40ce053f6f454522aede5b77a4a32553
- 출처 데이터셋
- uspto-grants-1988_02
- 특허 번호
- US04724236
연결된 노트
불러오는 중…